跳至主要内容
临床试验/NCT02553863
NCT02553863已完成不适用

A Randomised Controlled Trial to Assess the Effectiveness and Cost-effectiveness of Acupuncture in the Management of Chemotherapy-induced Peripheral Neuropathy

The Hong Kong Polytechnic University2 个研究点 分布在 1 个国家目标入组 87 人开始时间: 2015年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
87
试验地点
2
主要终点
Pain

研究概览

简要总结

The purpose of this study is to determine whether a course of acupuncture is effective in the management of peripheral neuropathy related pain in patients receiving chemotherapy.

详细描述

Participants and settings:

  • Patients with lung, breast, head & neck, colorectal or gynaecological cancer receiving taxanes or platinum-derivative chemotherapy experiencing CIPN after the end of cycle one will be the population of the study. The study will take place in a large cancer centre in the territory (Prince of Wales Hospital).

Recruitment:

  • Potential subjects will be identified (through clinic lists and databases of patients who are undergoing treatment) and approached initially by the relevant clinical team and screening then undertaken by research staff. The trial will be run ethically, details of which process can be seen under additional material.

Randomisation:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients with a diagnosis of lung cancer receiving chemotherapy with curative intend, and breast or gynaecological cancer, head & neck and colorectal cancer stage I, II or III.
  • Currently receiving neurotoxic chemotherapy (taxanes, cisplatin,,carboplatin, etc)
  • Reporting tingling in hands/feet and other indications of chemotherapy-induced peripheral neuropathy (CIPN) after initiation of cancer treatments, confirmed to be indicative of CIPN by a consultant.
  • Not using any medication for the prevention or treatment of CIPN for the past 31 months
  • Willing to participate and be randomised to one of the study groups.
  • No previously established peripheral neuropathy

排除标准

  • Exclusion criteria will include patients with needle phobia; Patients with low platelet count (<50,000); Comorbidity with a bleeding disorder; Pregnancy, or having received acupuncture treatment in the past three months. In addition, the ipsilateral arm of patients who have undergone axillary dissection will also be excluded from needling as well as lymphoedematous limbs.

研究组 & 干预措施

Intervention group

Experimental

Acupuncture for 30min [twice weekly for 8 weeks]

干预措施: Acupuncture (Procedure)

Control group

Other

Standard care

干预措施: Standard care (Procedure)

结局指标

主要结局

Pain

时间窗: at baseline, end of 8-week treatment, 14 weeks and 20 weeks (the latter two to assess possible longer term effects)

measured using the Brief Pain Inventory which measures pain intensity and its interference with function.

次要结局

  • Measurement of costs(at baseline, end of 8-week treatment, 14 weeks and 20 weeks (the latter two to assess possible longer term effects))
  • Severity of neuropathy(at baseline, end of 8-week treatment)
  • Grade of CIPN(at baseline, end of 8-week treatment)
  • Motor nerve conduction(at baseline, end of 8-week treatment)
  • Quality of life(at baseline, end of 8-week treatment, 14 weeks and 20 weeks (the latter two to assess possible longer term effects))
  • Sensory examination(at baseline, end of 8-week treatment)
  • Consumption of analgesics(at baseline, end of 8-week treatment, 14 weeks and 20 weeks (the latter two to assess possible longer term effects))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Alex MOLASIOTIS

Head of School, School of Nursing

The Hong Kong Polytechnic University

研究点 (2)

Loading locations...

相似试验